Dr. Taplin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
D1230
Boston, MA 02115Phone+1 617-582-7221Fax+1 617-632-2165
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1990 - 1993
- UMass Chan Medical SchoolResidency, Internal Medicine, 1986 - 1990
- University of Massachusetts Medical SchoolClass of 1986
Certifications & Licensure
- MA State Medical License 1987 - 2025
- NH State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy Start of enrollment: 1997 Jan 01
- A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer Start of enrollment: 2004 Jan 01
- Mifepristone (RU-486) in Androgen Independent Prostate Cancer Start of enrollment: 2005 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 62 citationsImmunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.Daniel Nava Rodrigues, Pasquale Rescigno, David Liu, Wei Yuan, Suzanne Carreira
The Journal of Clinical Investigation. 2018-11-01 - 798 citationsIntegrative clinical genomics of advanced prostate cancer.Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro
Cell. 2015-05-21 - 3283 citationsIncreased Survival with Enzalutamide in Prostate Cancer after ChemotherapyHoward I. Scher, Karim Fizazi, Fred Saad, Mary-Ellen Taplin, Cora N. Sternberg
The New England Journal of Medicine. 2012-09-26
Lectures
- PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to ...2019 ASCO Annual Meeting - 6/1/2019
- Optimizing Androgen Receptor Targeting Strategies Perspective2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Other
- Clinical presentation and diagnosis of prostate cancerTaplin M, Smith JA, Kantoff PW
http://www.uptodate.com/contents/clinical-presentation-and-diagnosis-of-prostate-cancer
UpToDate, Wolters Kluwer Health - 2013-02-05 - Initial staging and evaluation of men with newly diagnosed prostate cancerTaplin M, Smith JA, Kantoff PW
http://www.uptodate.com/contents/initial-staging-and-evaluation-of-men-with-newly-diagnosed-prostate
UpToDate, Wolters Kluwer Health - 2013-02-05 - Testicular sex cord stromal tumorsTaplin M
http://www.uptodate.com/contents/testicular-sex-cord-stromal-tumors
UpToDate, Wolters Kluwer Health - 2012-04-18
Authored Content
- Clinical and Genomic Characterization of Low–Prostate-Specific Antigen, High-Grade Prostate CancerFebruary 2018
Press Mentions
- Neoadjuvant NHAs Followed by Surgery Can Improve Key Outcomes in High-Risk Prostate Cancer PatientsSeptember 12th, 2022
- The Prostate Cancer Foundation Announces First Ever Pcf-Pfizer Global Health Equity Challenge Award WinnersApril 29th, 2022
- Rana R. McKay, MD: Developing Clinical Trials to Answer Questions Raised in PracticeApril 20th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: